                   AIDS INFORMATION NEWSLETTER
                   Michael Howe, MSLS, Editor
                     AIDS Information Center
                VA Medical Center, San Francisco
                     (415) 221-4810 ext 3305
                          June 16, 1995

               Opportunistic Infections (Part II)

[Editor's Note:  This is the first of three parts of a bibliography
that includes references for review articles for opportunistic
infections.  The general outline of the bibliography, which will
also be the outline for the series, is below and precedes the list
of references.]

                 Review Articles - Bibliography
                             Outline

I.   Overview Articles

II.  Clinical Syndromes
          A.  Diarrhea, Malabsorption, Wasting
          B.  Dermatitis
          C.  Fever

III. Infections - Fungal
          A.  Drugs
          B.  Candidiasis
          C.  Coccidioidomycosis
          D.  Cryptococcosis
          E.  Histoplasmosis

IV.  Infections - Mycobacterial
          A.  Mycobacterium avium Complex
          B.  Tuberculosis

V.   Infections - Parasitic
          A.  Review Articles - General
          B.  Cryptosporidiosis
          C.  Pneumocystis carinii Pneumonia
          D.  Toxoplasmosis

VI.  Infections - Viral
          A.  Drugs
          B.  Cytomegalovirus
          C.  Herpes Simplex/Zoster
          D.  Progressive Multifocal Leukoencephalopathy

VII. Infections - Other
          A. Syphilis/Neurosyphilis

VIII.     Malignancies
          A.  Review Article - General
          B.  Cervical Cancer
          C.  Kaposi's sarcoma
          D.  Non-Hodgkin's Lymphoma and Hodgkin's Disease
          E.  Squamous Cell Carcinoma


               BIBLIOGRAPHY OF OI REVIEW ARTICLES

I.  Overview Articles

     1.   Decker CF. Masur H. Current Status of Prophylaxis for
          Opportunistic Infections in HIV-Infected Patients. AIDS.
          1994;8:11-20.

     2.   Drugs for AIDS and Associated Infections. The Medical
          Letter on Drugs and Therapeutics. 1993 Sept;35(Issue
          904):79-86.

     3.   Gallant JE. Moore RD. Chaisson RE. Prophylaxis for
          Opportunistic Infections in Patients with HIV Infection.
          Annals of Internal Medicine. 1994:120:932-944.

     4.   Glaser CA. Angulo FJ. Rooney JA. Animal-Associated
          Opportunistic Infections Among Persons Infected with the
          Human Immunodeficiency Virus. Clinical Infectious
          Diseases. 1994;18:14-24.

     5.   Lane HC. Recent Advances in the Management of AIDS-
          Related Opportunistic Infections. Annals of Internal
          Medicine. 1994;120:945-955.

     6.   Lee BL. Safrin S. Interactions and Toxicities of Drugs
          Used in Patients with AIDS. Clinical Infectious Diseases.
          1992 Mar;14:773-9.

     7.   Smith GH. Treatment of Infections in the Patient with
          Acquired Immunodeficiency Syndrome. Archives of Internal
          Medicine. 1994;154:949-973.

     8.   VandenBriessche Thierry. Chuah MK. Morgan RA. Gene
          Therapy for Acquired Immune Deficiency Syndrome. AIDS
          Updates. 1994;7(4):1-14.

II. CLINICAL SYNDROMES

A. DIARRHEA, MALABSORPTION, WASTING

     1.   Asmuth DM. DeGirolami PC. Federman M. et al. Clinical
          Features of Microsporidiosis in Patients with AIDS.
          Clinical Infectious Diseases. 1994;18:819-25.

     2.   Cat LK. Coleman RL. Treatment for HIV Wasting Syndrome.
          Annals of Pharmacotherapy. 1994;28:595-597.

     3.   Coodley GO. Loveless MO. Merrill TM. The HIV Wasting
          Syndrome: A Review. Journal of Acquired Immune Deficiency
          Syndromes. 1994;7(7):681-694.

     4.   Gazzard BG. Diarrhea in Human Immunodeficiency Virus
          Antibody-Positive Patients. Seminars in Liver Disease.
          1992 Nov 2;12(2):154-166.

     5.   Grohmann GS. Glass RI. Pereira HG. et al. Enteric Viruses
          and Diarrhea in HIV-Infected Patients.  New England
          Journal of Medicine. 1993;329(1):14-20.

     6.   Grunfeld C. Kotler DP. Pathophysiology of the AIDS
          Wasting Syndrome.  In: Volberding P. Jacobson MA., Eds.,
          AIDS Clinical Review 1992. New York: Marcel Dekker, Inc.,
          1992:191-224.

     7.   Grunfeld C. Kotler DP. Wasting in the Acquired
          Immunodeficiency Syndrome. Seminars in Liver Disease.
          1992;12(2):175-87.

     8.   Keusch GT. Thea DM. Malnutrition in AIDS. Medical Clinics
          of North America. 1993 July;77(4):795-814.

     9.   Kotler DP. Wasting Syndrome: Nutritional Support in HIV
          Infection. AIDS Research and Human Retroviruses.
          1994;10(8):931-934.

     10.  Mayer HB. Wanke CA. Diagnostic Strategies in HIV-
          Infected Patients with Diarrhea. AIDS. 1994;8:1639-1648.

     11.  McGowan I. Hawkins AS. Weller ID. The Natural History of
          Cryptosporidial Diarrhoea in HIV-Infected Patients. AIDS.
          1993;7:349-54.

     12.  Molina JM. Sarfati C. Beavis B. et al. Intestinal
          Microsporidiosis in Human Immunodeficiency Virus Infected
          Patients with Chronic Unexplained Diarrhea: Prevalence
          and Clinical and Biologic Features. Journal of Infectious
          DIseases. 1993;167-217-21.

     13.  Rabeneck L. Diagnostic Workup Strategies for Patients
          with HIV-Related Chronic Diarrhea. Journal of Clinical
          Gastroenterology. 1993;16(3):245-50.

     14.  Rabeneck L. Gyorkey F. Genta RM. et al. The Role of
          Microsporidia in the Pathogenesis of HIV-Related Chronic
          Diarrhea. Annals of Internal Medicine. 1993;119(9):895-
          9.

     15.  Simon D. Weiss LM. Brandt LJ. Treatment Options for AIDS-
          Related Esophageal and Diarrheal Disorders. American
          Journal of Gastroenterology. 1992;87(3):274-81.

     16.  Singer P. Katz DP. Dillon L. et al. Nutritional Aspects
          of the Acquired Immunodeficiency Syndrome. American
          Journal of Gastroenterology. 1992;87(3):265-73.

     17.  Von Roenn JH. Management of HIV-Related Bodyweight Loss.
          Drugs. 1994;47(5):774-783.

     18.  Wurtz R. Cyclospora: A Newly Identified Intestinal
          Pathogen of Humans. Clinical Infectious Diseases.
          1994;18:620-3.

B.  DERMATITIS

     1.   Berger TG. Koehler JE. Bacillary Angiomatosis. In: AIDS
          Clinical Review 1993/1994. New York:Marcel Dekker, Inc.,
          1994:43-60.

     2.   Berger TG. Dermatological Aspects of HIV Disease: 1990
          Update. AIDS. 1990;4(Suppl 1):S223-S225.

     3.   Cockerell CJ. Human Immunodeficiency Virus Infection and
          the Skin: A Crucial Interface. Archives of Internal
          Medicine. 1991 Jul;151:1295-1303.

     4.   Cockerell CJ. Organ-Specific Manifestations of HIV
          Infections. II. Update on Cutaneous Manifestations of HIV
          Infection. AIDS. 1993;7(Suppl 1):S213-S218.

     5.   Cotell SL. Noskin GA. Bacillary Angiomatosis: Clinical
          and Histologic Features, Diagnosis, and Treatment.
          Archives of Internal Medicine. 1994;154:524-528.

     6.   Dover JS. Johnson RA. Cutaneous Manifestations of Human
          Immunodeficiency Virus Infection. Archives of
          Dermatology. Part I. 1991 Sept;127:1383-1391. Part II.
          1991 Oct;127:1549-1558.

     7.   Zalla MJ. Daniel WP. Fransway AF. Dermatologic
          Manifestations of Human Immunodeficiency Virus Infection.
          Mayo Clinic Proceedings. 1992 Nov;67:1089-1108.

C. FEVER

     1.   Durack DT. Street AC. Fever of Unknown Origin--Reexamined
          and Redefined. Current Clinical Topics in Infectious
          Diseases. 1991;11:35-51.

     2.   Kirby AJ. Munoz A. Detels R. et al. Thrush and Fever as
          Measures of Immunocompetence in HIV-1 Infected Men.
          Journal of Acquired Immune Deficiency Syndromes.
          1994;7:1242-1249.

     3.   Prego V. Glatt AE. Roy V. et al. Comparative Yield of
          Blood Culture for Fungi and Mycobacteria, Liver Biopsy,
          and Bone Marrow Biopsy in the Diagnosis of Fever of
          Undetermined Origin in Human Immunodeficiency Virus-
          Infected Patients. Archives of Internal Medicine. 1990
          Feb;150:333-6.

     4.   Sepkowitz KA. Telzak EE. Carrow M. et al. Fever Among
          Outpatients with Advanced Human Immunodeficiency Virus
          Infection. Arch of Internal Medicine. 1993;153:1909-12.

III. INFECTIONS - FUNGAL

A. DRUGS

     1.   Armstrong D. Treatment of Opportunistic Fungal
          Infections. Clinical Infectious Diseases. 1993 Jan;16:1-
          7.

     2.   Drugs for Treatment of Fungal Infections. The Medical
          Letter on Drugs and Therapeutics. 1992;34(Issue 864):14-
          6.

     3.   Elmets CA. Management of Common Superficial Fungal
          Infections in Patients with AIDS. Journal of the American
          Academy of Dermatology. 1994;31:S60-S63.

     4.   Fluconazole. Medical Letter on Drugs & Therapeutics.
          1990;32(818):50-2.

     5.   Itraconazole. The Medical Letter on Drugs and
          Therapeutics. 1993;35(Issue 888):7-9.

     6.   Stevens DA. Management of Systemic Manifestations of
          Fungal Disease in Patients with AIDS. Journal of the
          American Academy of Dermatology. 1994;31:S64-S67.

     7.   Systemic Antifungal Drugs. The Medical Letter on Drugs
          and Therapeutics. 1994;36(Issue 916):16-18.

B.  CANDIDIASIS

     1.   Garber GE. Fluconazole: A New Option in the Treatment of
          CAndida Mucositis and Esophageal Candidiasis. Journal of
          Otolaryngology. 1992;21(2):92-4.

     2.   Garber GE. Treatment of Oral Candida Mucositis
          Infections. Drugs. 1994;47(5):734-740.

     3.   Greenspan D. Treatment of Oral Candidiasis in HIV
          Infection. Oral Surgery Oral Medicine Oral Pathology.
          1994;78:211-215.

     4.   Greenspan D. Treatment of Oropharyngeal Candidiasis in
          HIV-Positive Patients. Journal of the American Academy
          of Dermatology. 1994;31:S51-S55.

     5.   Katz MH. Greenspan D. Westenhouse J. et al. Progression
          to AIDS in HIV-Infected Homosexual and Bisexual Men with
          Hairy Leukoplakia and Oral Candidiasis. AIDS. 1992;6:95-
          100.

     6.   Laine L. Dretler RH. Chris NC. Fluconazole Compared with
          Ketoconazole for the Treatment of Candida Esophagitis in
          AIDS: A Randomized Trial. Annals of Internal Medicine.
          1992;17:655-60.

     7.   McCarthy GM. Host Factors Associated With HIV-Related
          Oral Candidiasis: A Review. Oral Surgery, Oral Medicine,
          Oral Pathology. 1992 Feb;73(2):181-6. 

     8.   Pons V. Greenspan D. Debruin M. and the Multicenter Study
          Group. Therapy for Oropharyngeal Candidiasis in HIV-
          Infected Patients: A Randomized, Prospective Multicenter
          Study of Oral Fluconazole Versus Clotrimazole Troches.
          Journal of Acquired Immune Deficiency Syndromes. 1993
          Nov;6(12):1311-16.

     9.   Powderly WG. Resistant Candidiasis. AIDS Research and
          Human Retroviruses. 1994;10(8):925-929.

     10.  Samaramayake LP. Oral Mycoses in HIV Infection. Oral
          Surgery, Oral Medicine, Oral Pathology. 1992
          Feb;73(2):171-80.

     11.  Sobel JD. Controversial Aspects in the Management of
          Vulvovaginal Candidiasis. Journal of the American Academy
          of Dermatology. 1994;31:S10-S13.

C. COCCIDIOIDOMYCOSIS

     1.   Ampel NM. Dols CL. Galgiani JN. Coccidioidomycosis During
          Human Immunodeficiency Virus Infection: Results of a
          Prospective Study in a Coccidioidal Endemic Area.
          American Journal of Medicine. 1993 Mar;94;235-40.

     2.   Fish DG. Ampel NM. Galgiani JN. Cocidioidomycosis During
          Human Immunodeficiency Virus Infection: A Review of 77
          Patients. Medicine. 1990;69(6):384-91.

     3.   Galgiani JN. Coccidioidomycosis: Changes in Clinical
          Expression, Serological Diagnosis, and Therapeutic
          Options. Clinical Infectious Diseases. 1992;14(Suppl
          1):S100-5.

     4.   Galgiani JN. Catanzaro A. Cloud GA. et al. Fluconazole
          Therapy for Coccidioidal Meningitis. Annals of Internal
          Medicine. 1993 Jul;119(1):28-35.

D. CRYPTOCOCCOSIS

     1.   Coker RJ. Viviani M. Gazzard BG. et al. Treatment of
          Cryptococcosis with Liposomal Amphotericin B (AmBisome)
          in 23 Patients with AIDS. AIDS. 1993;7(6):829-35.

     2.   Dismukes WE. Management of Cryptococcosis. Clinical
          Infectious Diseases. 1993;17(Suppl 2):S507-12.

     3.   Nelson MR. Fisher M. Cartledge J. et al. The Role of
          Azoles in the Treatment and Prophylaxis of Cryptococcal
          Disease in HIV Infection. AIDS. 1994;8:651-654.

     4.   Powderly WG. Cryptococcal Meningitis and AIDS. Clinical
          Infectious Diseases. 1993;17:837-42.

     5.   Powderly WG. New Developments in the Treatment of
          Cryptococcal Disease in AIDS. In: AIDS Clinical Review
          1993/1994. New York: Marcel Dekker, Inc., 1994:113-28.

     6.   Powderly WG. Therapy for Cryptococcal Meningitis in
          Patients with AIDS. Clinical Infectious Diseases.
          1992;14(Suppl 1):S54-9.

     7.   Powderly WG. Cloud GA. Dismukes WE. et al. Measurement
          of Cryptococcal Antigen in Serum and Cerebrospinal Fluid:
          Value in the Management of AIDS-Associated Cryptococcal
          Meningitis. Clinical Infectious Diseases. 1994;18:789-
          92.

     8.   White M. Cirrincione C. Blevens A. et al. Cryptococcal
          Meningitis: Outcome in Patients with AIDS and Patients
          with Neoplastic Disease. Journal of Infectious Diseases.
          1992;165:960-3.

     9.   White MH. Armstrong D. Cryptococcosis. Infectious Disease
          Clinics of North America. 1994;8(2):383-398.

E. HISTOPLASMOSIS

     1.   Drew RH. Pharmacotherapy of Disseminated Histoplasmosis
          in Patients with AIDS. Annals of Pharmacotherapy. 1993
          Dec;27:1510-8.

     2.   McKinsey DS. Driks MR. Histoplasmosis in HIV Disease. The
          AIDS Reader. 1993;3(6):203-9.

     3.   Norris S. Wheat J. McKinsey D. et al. Prevention of
          Relapse of Histoplasmosis with Fluconazole in Patients
          with the Acquired Immunodeficiency Syndrome. American
          Journal of Medicine. 1994;96:504-508.

     4.   Sarosi GA. Johnson PC. Disseminated Histoplasmosis in
          Patients Infected with Human Immunodeficiency Virus.
          Clinical Infectious Diseases. 1992;14(Suppl 1):S60-7.

     5.   Sharkey-Mathis PK. Velez J. Fetchick R. et al.
          Histoplasmosis in the Acquired Immunodeficiency Syndrome
          (AIDS): Treatment with Itraconazole and Fluconazole.
          Journal of AIDS. 1993;6:809-19.

     6.   Wheat J. Histoplasmosis and Coccidioidomycosis in
          Individuals with AIDS: A Clinical Review. Infectious
          Disease Clinics of North America. 1994;8(20):467-482.

     7.   Wheat J. Histoplasmosis: Recognition and Treatment.
          Clinical Infectious Diseases. 1994;19(Suppl 1):S19-27.

     8.   Wheat J. Hafner R. Wulfsohn M. et al. Prevention of
          Relapse of Histoplasmosis with Itraconazole in Patients
          with the Acquired Immunodeficiency Syndrome. Annals of
          Internal Medicine. 1993 Apr;118(8):610-16.

     9.   Wheat LJ. Connolly-Stringfield PA. Baker RL. et al.
          Disseminated Histoplasmosis in the Acquired Immune
          Deficiency Syndrome: Clinical Findings, Diagnosis and
          Treatment, and Review of the Literature. Medicine. 1990
          Nov;69(6):361-74.
